Intra-myocardial biomaterial injection therapy in the treatment of heart failure: Materials, outcomes and challenges

Acta Biomaterialia

Volumn 7, Issue 1, 2011, Pages 1-15

  Nelson, Devin M ^a   Ma, Zuwei ^b,c   Fujimoto, Kazuro L ^b,c   Hashizume, Ryotaro ^b,c   Wagner, William R ^a,b,c  

^a University of Pittsburgh   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cardiac tissue engineering; Hydrogels; Injectable biomaterial; Myocardial infarction; Thermoresponsive polymer

Indexed keywords

DEGRADATION; DISEASE CONTROL; DISEASES; HEART; HYBRID MATERIALS; HYDROGELS; TISSUE ENGINEERING;

CARDIAC TISSUE ENGINEERING; CONDITION; CORONARY ARTERY DISEASE; DISEASE PROGRESSION; FUNCTIONAL IMPROVEMENTS; HEART FAILURE; INJECTABLE BIOMATERIALS; MYOCARDIAL INFARCTION; THERMORESPONSIVE POLYMER; VENTRICULAR WALLS;

CARDIOLOGY;

ACRYLAMIDE DERIVATIVE; ALGINIC ACID; ALPHA CYCLODEXTRIN; ARGINYLGLYCYLASPARTIC ACID; ASPARAGINYLALANYLASPARAGINYLALANYLASPARTYLALANYLASPARTYLALANYL ASPARAGINYLALANYLASPARAGINYLALANYLASPARTYLALANYLASPARTYLALANYLCYSTEINE AMINE; BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; CARBONIC ACID DERIVATIVE; CARBOXYMETHYLCELLULOSE; CHITOSAN; CHITOSAN DERIVATIVE; ERYTHROPOIETIN; FIBRIN; GELATIN; HYALURONIC ACID DERIVATIVE; HYDROXYAPATITE; HYDROXYETHYLCELLULOSE; LACTONE DERIVATIVE; MACROGOL DERIVATIVE; METHACRYLIC ACID DERIVATIVE; METHOXY POLY(ETHYLENE GLYCOL) POLY(CAPROLACTONE) (DODECANEDIOIC ACID) POLY(CAPROLCTONE) METHOXY POLY(ETHYLENE GLYCOL); N ISOPROPYL ACRYLAMIDE CO ACRYLIC ACID CO HYDROXYL ETHYL METHACRYLATE POLY(TRIMETHYLENE CARBONATE); NANOFIBER; PEPTIDE DERIVATIVE; PLEIOTROPHIN; RADIESSE; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; TYROSYLISOLEUCYLGLYCYLSERYLARGININE; UNCLASSIFIED DRUG;

CAPILLARY DENSITY; CARDIAC RESTRAINT DEVICE; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR PROCEDURES; CELL ADHESION; CELL INFILTRATION; CELL SURVIVAL; CELL THERAPY; DRUG DELIVERY SYSTEM; DRUG EFFECT; EMBRYONIC STEM CELL; EQUIPMENT DESIGN; EXTRACELLULAR MATRIX; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HEMATOPOIETIC STEM CELL; HUMAN; HYDROGEL; INJECTION; INTRACORONARY INFUSION; INTRAMYOCARDIAL BIOMATERIAL INJECTION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; THERAPY EFFECT;

ANIMALIA;

EID: 78049437297     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.06.039     Document Type: Review

References (125)

1. M. Jessup, and S. Brozena Heart failure N Engl J Med 348 2003 2007 2018
2. E.L. Hannan A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty J Am Coll Cardiol 33 1999 63 72
3. E.L. Hannan Long-term outcomes of coronary-artery bypass grafting versus stent implantation N Engl J Med 352 2005 2174 2183
4. G.S. Nelson Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block Circulation 102 2000 3053 3059
5. M.D. Flather Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients Lancet 355 2000 1575 1581
6. P.A. van Zwieten Current and newer approaches in the drug treatment of congestive heart failure Cardiovasc Drugs Ther 10 1997 693 702
7. R. John Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy Ann Thorac Surg 72 2001 440 449
8. D.J. Goldstein, M.C. Oz, and E.A. Rose Implantable left ventricular assist devices N Engl J Med 339 1998 1522 1533
9. M.A. Simon, J. Watson, J.T. Baldwin, W.R. Wagner, and H.S. Borovetz Current and future considerations in the use of mechanical circulatory support devices Annu Rev Biomed Eng 10 2008 59 84
10. K.L. Christman, and R.J. Lee Biomaterials for the treatment of myocardial infarction J Am Coll Cardiol 48 2006 907 913
11. J.W. Holmes, T.K. Borg, and J.W. Covell Structure and mechanics of healing myocardial infarcts Annu Rev Biomed Eng 7 2005 223 253
12. K.B. Gupta, M.B. Ratcliffe, M.A. Fallert, L.H. Edmunds Jr., and D.K. Bogen Changes in passive mechanical stiffness of myocardial tissue with aneurysm formation Circulation 89 1994 2315 2326
13. M.A. Pfeffer, and E. Braunwald Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1990 1161 1172
14. R.H. Schwinger The failing human heart is unable to use the Frank-Starling mechanism Circ Res 74 1994 959 969
15. H.D. White, R.M. Norris, M.A. Brown, P.W. Brandt, R.M. Whitlock, and C.J. Wild Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction Circulation 76 1987 44 51
16. M.D. Tischler, J. Niggel, D.T. Borowski, and M.M. LeWinter Relation between left ventricular shape and exercise capacity in patients with left ventricular dysfunction J Am Coll Cardiol 22 1993 751 757
17. M.A. Pfeffer, and J.M. Pfeffer Ventricular enlargement and reduced survival after myocardial infarction Circulation 75 1987 IV93 IV97
18. T. Tonnessen, and C.W. Knudsen Surgical left ventricular remodeling in heart failure Eur J Heart Fail 7 2005 704 709
19. R.C. Starling Sustained benefits of the CorCap cardiac support device on left ventricular remodeling: three year follow-up results from the Acorn clinical trial Ann Thorac Surg 84 2007 1236 1242
20. C.T. Klodell Jr. Worldwide surgical experience with the Paracor HeartNet cardiac restraint device J Thorac Cardiovasc Surg 135 2008 188 195
21. J.F. Gummert, A. Rahmel, T. Bossert, and F.W. Mohr Socks for the dilated heart. Does passive cardiomyoplasty have a role in long-term care for heart failure patients? Z Kardiol 93 2004 849 854
22. A.S. Blom Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep Heart Fail Rev 10 2005 125 139
23. K. Fukamachi, and P.M. McCarthy Initial safety and feasibility clinical trial of the myosplint device J Card Surg 20 2005 S43 S47
24. A. Kashem Early and late results of left ventricular reshaping by passive cardiac-support device in canine heart failure J Heart Lung Transplant 22 2003 1046 1053
25. U. Sartipy, A. Albage, and D. Lindblom The Dor procedure for left ventricular reconstruction. Ten-year clinical experience Eur J Cardiothorac Surg 27 2005 1005 1010
26. R. Batista Partial left ventriculectomy - the Batista procedure Eur J Cardiothorac Surg 15 Suppl. 1 1999 S12 S19 (discussion S39-S43)
27. K.L. Fujimoto An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction J Am Coll Cardiol 49 2007 2292 2300
28. S.T. Wall, J.C. Walker, K.E. Healy, M.B. Ratcliffe, and J.M. Guccione Theoretical impact of the injection of material into the myocardium: a finite element model simulation Circulation 114 2006 2627 2635
29. J.F. Wenk A method for automatically optimizing medical devices for treating heart failure: designing polymeric injection patterns J Biomech Eng 131 2009 1210111 1210117
30. J.A. Rowley, G. Madlambayan, and D.J. Mooney Alginate hydrogels as synthetic extracellular matrix materials Biomaterials 20 1999 45 53
31. E. Alsberg, K.W. Anderson, A. Albeiruti, R.T. Franceschi, and D.J. Mooney Cell-interactive alginate hydrogels for bone tissue engineering J Dent Res 80 2001 2025 2029
32. A.D. Augst, H.J. Kong, and D.J. Mooney Alginate hydrogels as biomaterials Macromol Biosci 6 2006 623 633
33. H.J. Kong, K.Y. Lee, and D.J. Mooney Decoupling the dependence of rheological/mechanical properties of hydrogels from solids concentration Polymer 43 2002 6239 6246
34. J.L. Drury, R.G. Dennis, and D.J. Mooney The tensile properties of alginate hydrogels Biomaterials 25 2004 3187 3199
35. B.J. Stokke, K.I. Draget, O. Smidsrod, Y. Yuguchi, H. Urakawa, and K. Kajiwara Small-angle X-ray scattering and rheological characterization of alginate gels. 1. Ca-alginate gels Macromolecules 33 2000 1853 1863
36. K.H. Bouhadir, K.Y. Lee, E. Alsberg, K.L. Damm, K.W. Anderson, and D.J. Mooney Degradation of partially oxidized alginate and its potential application for tissue engineering Biotechnol Prog 17 2001 945 950
37. H.H. Tonnesen, and J. Karlsen Alginate in drug delivery systems Drug Dev Ind Pharm 28 2002 621 630
38. C.A. Simmons, E. Alsberg, S. Hsiong, W.J. Kim, and D.J. Mooney Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells Bone 35 2004 562 569
39. N. Landa Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat Circulation 117 2008 1388 1396
40. O. Tsur-Gang The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction Biomaterials 30 2009 189 195
41. J. Yu, K.L. Christman, E. Chin, R.E. Sievers, M. Saeed, and R.J. Lee Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy J Thorac Cardiovasc Surg 137 2009 180 187
42. X. Hao Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction Cardiovasc Res 75 2007 178 185
43. S.S. Mihardja, R.E. Sievers, and R.J. Lee The effect of polypyrrole on arteriogenesis in an acute rat infarct model Biomaterials 29 2008 4205 4210
44. R. Mukherjee Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs Ann Thorac Surg 86 2008 1268 1276
45. J. Yu, Y. Gu, K.T. Du, S. Mihardja, R.E. Sievers, and R.J. Lee The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model Biomaterials 30 2009 751 756
46. B. Garner, A. Georgevich, A.J. Hodgson, L. Liu, and G.G. Wallace Polypyrrole-heparin composites as stimulus-responsive substrates for endothelial cell growth J Biomed Mater Res 44 1999 121 129 (Pubitemid 28566799)
47. J. Leor Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine J Am Coll Cardiol 54 2009 1014 1023
48. D.S. Lee, P.C. Austin, J.L. Rouleau, P.P. Liu, D. Naimark, and J.V. Tu Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587
49. A. Breen, T. O'Brien, and A. Pandit Fibrin as a delivery system for therapeutic drugs and biomolecules Tissue Eng Part B Rev 15 2009 201 214
50. M.R. Jackson Fibrin sealants in surgical practice. An overview Am J Surg 182 2001 1S 7S
51. D.H. Sierra Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications J Biomater Appl 7 1993 309 352
52. D.H. Sierra, A.W. Eberhardt, and J.E. Lemons Failure characteristics of multiple-component fibrin-based adhesives J Biomed Mater Res 59 2002 1 11
53. K.L. Christman, H.H. Fok, R.E. Sievers, Q. Fang, and R.J. Lee Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction Tissue Eng 10 2004 403 409
54. K.L. Christman, A.J. Vardanian, Q. Fang, R.E. Sievers, H.H. Fok, and R.J. Lee and induces neovasculature formation in ischemic myocardium J Am Coll Cardiol 44 2004 654 660
55. K.L. Christman, Q. Fang, M.S. Yee, K.R. Johnson, R.E. Sievers, and R.J. Lee Enhanced neovasculature formation in ischemic myocardium following delivery of pleiotrophin plasmid in a biopolymer Biomaterials 26 2005 1139 1144
56. N.F. Huang, J. Yu, R. Sievers, S. Li, and R.J. Lee Injectable biopolymers enhance angiogenesis after myocardial infarction Tissue Eng 11 2005 1860 1866
57. F.A. Auger, R. Guignard, C.A. López Valle, and L. Germain Role and innocuity of Tisseel®, a tissue glue, in the grafting process and in vivo evolution of human cultured epidermis Br J Plast Surg 46 1993 136 142
58. I.Y. Kim Chitosan and its derivatives for tissue engineering applications Biotechnol Adv 26 2008 1 21
59. E. Khor, and L.Y. Lim Implantable applications of chitin and chitosan Biomaterials 24 2003 2339 2349
60. A. Chenite Novel injectable neutral solutions of chitosan form biodegradable gels in situ Biomaterials 21 2000 2155 2161
61. J.M. Dang, D.D. Sun, Y. Shin-Ya, A.N. Sieber, J.P. Kostuik, and K.W. Leong Temperature-responsive hydroxybutyl chitosan for the culture of mesenchymal stem cells and intervertebral disk cells Biomaterials 27 2006 406 418
62. W.N. Lu Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel Tissue Eng Part A 15 2009 1437 1447
63. Y. Yeo, W. Geng, T. Ito, D.S. Kohane, J.A. Burdick, and M. Radisic Photocrosslinkable hydrogel for myocyte cell culture and injection J Biomed Mater Res B Appl Biomater 81 2007 312 322
64. M. Dobaczewski, C. Gonzalez-Quesada, and N.G. Frangogiannis The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction J Mol Cell Cardiol 48 2009 504 511
65. R.L. Juliano, and S. Haskill Signal transduction from the extracellular matrix J Cell Biol 120 1993 577 585
66. S.F. Badylak, T.W. Gilbert, and D.O. Freytes Extracellular matrix as a biological scaffold material: Structure and function Acta Biomater 5 2009 1 13
67. K. Tomihata, K. Burczak, K. Shiraki, and Y. Ikada Cross-linking and biodegradation of native and denatured collagen. In: polymers of biological and biomedical significance 1993 American Chemical Society Washington, DC pp. 275-286
68. V.H. Barocas, A.G. Moon, and R.T. Tranquillo The fibroblast-populated collagen microsphere assay of cell traction force - Part 2: measurement of the cell traction parameter J Biomech Eng 117 1995 161 170
69. E.J. Semler, C.S. Ranucci, and P.V. Moghe Mechanochemical manipulation of hepatocyte aggregation can selectively induce or repress liver-specific function Biotechnol Bioeng 69 2000 359 369
70. Z.Q. Shao Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model Circ J 70 2006 471 477
71. W. Dai, L.E. Wold, J.S. Dow, and R.A. Kloner Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction J Am Coll Cardiol 46 2005 714 719
72. T. Kofidis Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle J Thorac Cardiovasc Surg 128 2004 571 578
73. T. Kofidis, D.R. Lebl, E.C. Martinez, G. Hoyt, M. Tanaka, and R.C. Robbins Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury Circulation 112 2005 I173 I177
74. Z.Q. Zhao Improvement in cardiac function with small intestine extracellular matrix is associated with recruitment of C-kit cells, myofibroblasts, and macrophages after myocardial infarction J Am Coll Cardiol 55 2010 1250 1261
75. J.M. Singelyn, J.A. Dequach, S.B. Seif-Naraghi, R.B. Littlefield, P.J. Schup-Magoffin, and K.L. Christman Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering Biomaterials 30 2009 5409 5416
76. S.B. Seif-Naraghi, M.A. Salvatore, P.J. Schup-Magoffin, D.P. Hu, and K.L. Christman Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering Tissue Eng Part A 16 2010 1017 1027
77. Ifkovits JL, et al. Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci USA; doi:10.1073/pnas.1004097107.
78. S. Zhang Fabrication of novel biomaterials through molecular self-assembly Nat Biotechnol 21 2003 1171 1178
79. X. Zhao, and S. Zhang Molecular designer self-assembling peptides Chem Soc Rev 35 2006 1105 1110
80. D.A. Narmoneva, R. Vukmirovic, M.E. Davis, R.D. Kamm, and R.T. Lee Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration Circulation 110 2004 962 968
81. T.C. Holmes Novel peptide-based biomaterial scaffolds for tissue engineering Trends Biotechnol 20 2002 16 21
82. M.E. Davis Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells Circulation 111 2005 442 450
83. P.C. Hsieh, C. MacGillivray, J. Gannon, F.U. Cruz, and R.T. Lee Local controlled intramyocardial delivery of platelet-derived growth factor improves postinfarction ventricular function without pulmonary toxicity Circulation 114 2006 637 644
84. P.C. Hsieh, M.E. Davis, J. Gannon, C. MacGillivray, and R.T. Lee Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers J Clin Invest 116 2006 237 248
85. V.F. Segers, T. Tokunou, L.J. Higgins, C. MacGillivray, J. Gannon, and R.T. Lee Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction Circulation 116 2007 1683 1692
86. A.S. Hoffman Hydrogels for biomedical applications Adv Drug Deliv Rev 54 2002 3 12
87. X. Zheng Shu, Y. Liu, F.S. Palumbo, Y. Luo, and G.D. Prestwich In situ crosslinkable hyaluronan hydrogels for tissue engineering Biomaterials 25 2004 1339 1348
88. D.-A. Wang, C.G. Williams, Q. Li, B. Sharma, and J.H. Elisseeff Synthesis and characterization of a novel degradable phosphate-containing hydrogel Biomaterials 24 2003 3969 3980
89. J. Li, X. Ni, and K.W. Leong Injectable drug-delivery systems based on supramolecular hydrogels formed by poly(ethylene oxide)s and alpha-cyclodextrin J Biomed Mater Res Part A 65A 2003 196 202
90. B.H. Lee, and B. Vernon In situ-gelling, erodible N-isopropylacrylamide copolymers Macromol Biosci 5 2005 629 635
91. D.Q. Wu Fabrication of supramolecular hydrogels for drug delivery and stem cell encapsulation Langmuir 24 2008 10306 10312
92. X.J. Jiang Injection of a novel synthetic hydrogel preserves left ventricle function after myocardial infarction J Biomed Mater Res A 90 2009 472 477
93. T. Wang The inhibition of postinfarct ventricle remodeling without polycythaemia following local sustained intramyocardial delivery of erythropoietin within a supramolecular hydrogel Biomaterials 30 2009 4161 4167
94. S. Dobner, D. Bezuidenhout, P. Govender, P. Zilla, and N. Davies A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling J Card Fail 15 2009 629 636
95. B. Jeong, S.W. Kim, and Y.H. Bae Thermosensitive sol-gel reversible hydrogels Adv Drug Deliv Rev 54 2002 37 51
96. J. Guan, Y. Hong, Z. Ma, and W.R. Wagner Protein-reactive, thermoresponsive copolymers with high flexibility and biodegradability Biomacromolecules 9 2008 1283 1292
97. Ma Z, Nelson DM, Hong Y, Wagner WR. Thermally responsive injectable hydrogel incorporating methacrylate-polylactide for hydrolytic lability. Biomacromolecules. doi:10.1021/bm1004299.
98. F. Wang Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers Acta Biomater 6 2010 1978 1991
99. S. Kim, and K.E. Healy Synthesis and characterization of injectable poly(N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links Biomacromolecules 4 2003 1214 1223
100. R.A. Stile, and K.E. Healy Thermo-responsive peptide-modified hydrogels for tissue regeneration Biomacromolecules 2 2001 185 194
101. K.L. Fujimoto Synthesis, characterization and therapeutic efficacy of a biodegradable, thermoresponsive hydrogel designed for application in chronic infarcted myocardium Biomaterials 30 2009 4357 4368
102. D.Q. Wu, F. Qiu, T. Wang, X.J. Jiang, X.Z. Zhang, and R.X. Zhuo Toward the development of partially biodegradable and injectable thermoresponsive hydrogels for potential biomedical applications ACS Appl Mater Interfaces 1 2009 319 327
103. T. Wang Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling Eur J Heart Fail 11 2009 14 19
104. L.P. Ryan Dermal filler injection: a novel approach for limiting infarct expansion Ann Thorac Surg 87 2009 148 155
105. P.F. Jacovella Use of calcium hydroxylapatite (Radiesse) for facial augmentation Clin Interv Aging 3 2008 161 174
106. T.P. Richardson, M.C. Peters, A.B. Ennett, and D.J. Mooney Polymeric system for dual growth factor delivery Nat Biotechnol 19 2001 1029 1034
107. R.R. Chen, E.A. Silva, W.W. Yuen, and D.J. Mooney Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation Pharm Res 24 2007 258 264
108. M.E. Davis Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction Proc Natl Acad Sci USA 103 2006 8155 8160
109. V.F. Segers, and R.T. Lee Stem-cell therapy for cardiac disease Nature 451 2008 937 942
110. K.C. Wollert, and H. Drexler Clinical applications of stem cells for the heart Circ Res 96 2005 151 163
111. M.A. Laflamme, and C.E. Murry Regenerating the heart Nat Biotechnol 23 2005 845 856
112. P. Menasche Skeletal myoblasts as a therapeutic agent Prog Cardiovasc Dis 50 2007 7 17
113. P. Menasche Cellular transplantation: hurdles remaining before widespread clinical use Curr Opin Cardiol 19 2004 154 161
114. J. Muller-Ehmsen Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium J Mol Cell Cardiol 34 2002 107 116
115. J. Muller-Ehmsen Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction J Mol Cell Cardiol 41 2006 876 884
116. N. Dib Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the international society for cardiovascular translational research JACC Cardiovasc Interv 3 2010 265 275
117. T. Ota N.A. Patronik, D. Schwartzman, C.N. Riviere, M.A. Zenati. Minimally invasive epicardial injections using a novel semiautonomous robotic device Circulation 118 2008 S115 S120
118. H. Zhang Injection of bone marrow mesenchymal stem cells in the borderline area of infarcted myocardium: heart status and cell distribution J Thorac Cardiovasc Surg 134 2007 1234 1240
119. S.L. Hale, W. Dai, J.S. Dow, and R.A. Kloner Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment Life Sci 83 2008 511 515
120. C.C. Wang Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction Cardiovasc Res 77 2008 515 524
121. W. Dai, S.L. Hale, G.L. Kay, A.J. Jyrala, and R.A. Kloner Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology Regen Med 4 2009 387 395
122. J. Nussbaum Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response FASEB J 21 2007 1345 1357
123. T. Wang Bone marrow stem cells implantation with alpha-cyclodextrin/MPEG- PCL-MPEG hydrogel improves cardiac function after myocardial infarction Acta Biomater 5 2009 2939 2944
124. M.E. Padin-Iruegas Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction Circulation 120 2009 876 887
125. K. Hayakawa Inhibition of granulation tissue cell apoptosis during the subacute stage of myocardial infarction improves cardiac remodeling and dysfunction at the chronic stage Circulation 108 2003 104 109